Company overview
Basic information
Company name
Šviesos architektai, MB
Company code
306989296
VAT code
LT100017441614
Registered address
Šilutė, Ventės g. 31, LT-99169
Registration date
2024-09-12
Company age: 2 y. 1 mo.
Contact information
Edit data
Phone
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Email
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Website
None
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Small partnership
NACE activity
Other support activities to arts and performing arts
Ownership form
Private without foreign capital
Šviesos architektai, MB
Company code: 306989296
Address: Šilutė, Ventės g. 31, LT-99169
VAT code: LT100017441614
Description
This description was generated by artificial intelligence.
Šviesos architektai, MB (company code 306989296) is an operational private small partnership registered on 12 September 2024. It is a micro company within the sector of national private non-financial companies, with CEO-only governance. The ownership structure is private, with Lithuanian natural and legal persons holding more than 50% of the authorised capital and no foreign investor capital. The company is based in Šilute, Ventes g. 31, Šilutes r. sav., Klaipedos apskr. Its registered activity is S.90.39.00, Other support activities to arts and performing arts. In the 2025 financial year, revenue increased to EUR 33.5K, up 62.8% from the previous year. Net profit was EUR 51, compared with EUR 6.0K in 2024, and the profit margin was 0.2%. Equity stood at EUR 6.0K, liabilities at EUR 2.0K, and total assets at EUR 24.7K. Long-term assets amounted to EUR 18.6K and short-term assets to EUR 6.1K. Overall, the company remained small and profitable, although with very limited earnings in 2025.
Download a detailed company report
Make confident decisions with all the information about Šviesos architektai, MB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.